Venetoclax and ibrutinib therapy shows favourable results in the treatment of R/R chronic lymphocytic leukaemia

Radiation therapy after radical surgery in prostate cancer

Pembrolizumab benefits patients with brain metastases

Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma

ADCLEC.syn1 and CD33-CARS in humanised acute myeloid leukaemia models shows promising efficacy

Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer

The parotid gland; an unusual site of colorectal cancer metastasis

Real-world behavioural restrictional practices of cancer patients

iCCaRE Consortium for Black Men: Second Discussion

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine improves PFS in N2-3 nasopharyngeal carcinoma

CDK4/6 inhibitors added to first line show no greater benefit when compared to their use in second line therapy in HR+, HER2- ABC